Market Capitalization (Millions $) |
34 |
Shares
Outstanding (Millions) |
13 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-15 |
Cash Flow (TTM) (Millions $) |
-2 |
Capital Exp. (TTM) (Millions $) |
0 |
Acurx Pharmaceuticals Inc
Acurx Pharmaceuticals Inc. is a pharmaceutical company that focuses on the development and commercialization of novel antibiotics for the treatment of bacterial infections. They have a particular emphasis on targeting gastrointestinal infections caused by Clostridioides difficile (C. difficile). The company's mission is to address the growing problem of antibiotic-resistant infections by developing innovative and effective therapies. They are committed to improving patient outcomes and providing healthcare professionals with new treatment options for difficult-to-treat infections.
Company Address: 259 Liberty Ave. Staten Island 10305 NY
Company Phone Number: 533-1469 Stock Exchange / Ticker: NASDAQ ACXP
|